Cargando…
Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors
MicroRNA-381 (miR-381) is a highly expressed onco-miRNA that is involved in malignant progression and has been suggested to be a good target for glioblastoma multiforme (GBM) therapy. In this study, we employed two-dimensional fluorescence differential gel electrophoresis (2-D DIGE) and MALDI–TOF/TO...
Autores principales: | Wang, Zeyou, Yang, Jing, Xu, Gang, Wang, Wei, Liu, Changhong, Yang, Honghui, Yu, Zhibin, Lei, Qianqian, Xiao, Lan, Xiong, Jing, Zeng, Liang, Xiang, Juanjuan, Ma, Jian, Li, Guiyuan, Wu, Minghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413644/ https://www.ncbi.nlm.nih.gov/pubmed/25605243 |
Ejemplares similares
-
Disturbing miR-182 and -381 Inhibits BRD7 Transcription and Glioma Growth by Directly Targeting LRRC4
por: Tang, Hailin, et al.
Publicado: (2014) -
The EGFR-ZNF263 signaling axis silences SIX3 in glioblastoma epigenetically
por: Yu, Zhibin, et al.
Publicado: (2020) -
Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma
por: Li, Yunchao, et al.
Publicado: (2016) -
Association of NEFL Gene Polymorphisms with Wilms' Tumor Susceptibility in Chinese Children
por: Jia, Wei, et al.
Publicado: (2019) -
Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis
por: Jin, Dan, et al.
Publicado: (2020)